Historically, healthcare organizations have followed the lead of published research on the efficacy of pharmacokinetic (PK) models to support point-of-care precision dosing. When a respected journal publishes a robust, peer-validated PK model analysis, clinicians often heed the results and accept that model as their organization’s default for the drug in question. However, new research shows…